Equities
APLS – Technical Market Research
Apellis Pharmaceuticals surges 135% on Biogen’s $41/share acquisition offer. Full technical and fundamental breakdown of the deal and what it means for the tape.
sector:healthcare
Healthcare sector
Equities
WVE – Technical Market Research
WVE cratered 49.6% on INLIGHT dose-response data. RSI at 19.41, volume 15x average — is this capitulation or the beginning of further downside? Rachel Kensington lays out the levels.
Equities
KOD – Technical Market Research
KOD surged 75% on GLOW2 Phase 3 success for tarcocimab (Zenkuda). RSI at 89 — deep overbought. The setup now is about defining where the mean-reversion risk is real vs. where momentum continues.
Research
CTMX – Technical Market Research
Comprehensive technical analysis of CTMX covering price action, momentum, fundamental context, and the macro backdrop.
Research
AIRS – Technical Market Research
Comprehensive technical analysis of AIRS covering price action, momentum, fundamental context, and the macro backdrop.
Equities
Hims & Hers (HIMS): Massive Earnings Bounce Off Yearly Lows — March 10, 2026
Comprehensive technical analysis of HIMS covering price action, momentum, fundamental context, and the macro backdrop.